1.
Abstract
2.
Treatment
3. Background
4. Objectives
5. Criteria for including studies
6.
Search strategy
7. Data collection and evaluation of studies
8.
Description of studies
9.
Methodological quality
10. Results
11. Discussion of findings
12. Conclusions
13. References
14.
Further Resources
1.
Abstract
Radiotherapy and
chemotherapy treatments for cancer can have significant side effects. Many
people being treated for cancer use alternative and complementary medicines.
Homoeopathy is used by some people with cancer to alleviate the symptoms
caused by the disease or the treatment.
Homoeopathic treatment
involves giving extremely small doses of a substance (called a ‘remedy’) in
a very dilute solution. The remedy is selected based on the total picture of
the person and their symptoms, not just the symptoms of the illness. Various
aspects of the person are considered, including their lifestyle, emotions,
mental state and nutrition. (Vickers and Zollman 1999)
There is evidence that
homoeopathy may reduce side-effects of radiotherapy, reduce the severity and
duration of chemotherapy-induced stomatitis and reduce the total severity of
skin reaction to radiotherapy.
There is
evidence that homoeopathy does not reduce severity or frequency of
menopausal symptoms in breast cancer survivors and may, in women not taking
tamoxifen, increase the severity and number of hot flushes.
There is also evidence in this group of women
that there was an increase in number and severity of hot flushes taking the
combination remedy and an increase in the number of headaches. No other side
effects were reported in any of the studies.
Back to top
2.
Treatment
Type of treatment:
Homoeopathy
3.
Background
Cancer is a
common cause of death in developed countries. The non-surgical treatments,
including radiotherapy and chemotherapy, can have significant side effects
that can limit their use. Side effects from radiotherapy include tiredness,
flu-like symptoms, loss of appetite, weight loss, reddened hot sensitive
skin, pigmented skin, menopause-like symptoms, and emotional symptoms.
Chemotherapy side effects include fatigue, nausea or vomiting, loss of
appetite, diarrhoea, constipation, hair loss,
mouth ulcers and dry, pigmented or sunlight sensitive skin.
http://www.cancerhelp.org.uk/default.asp
A recent survey
(Molassiotis, Fernadez-Ortega et al. 2005) has
shown that homoeopathy is one of the commonest used complementary therapies
for cancer. As a complementary treatment, homoeopathy is used mainly to
strengthen the body, improve well-being and to alleviate symptoms caused by
the disease or the treatment. (Milazzo, Russell et al. 2006)
Homoeopathy is a system of
medicine developed in the late 1700s in Germany by Samuel Hahnemann.
Homoeopathic treatment
involves giving extremely small doses of a substance (called a ‘remedy’)
that, if given to a healthy person in larger doses, will cause the same or
similar symptoms. This is the principle of similars or “like cures like”.
Most homoeopathic remedies are derived from natural substances that come
from plants, minerals or animals.
These remedies are prepared
by a process of successive dilution and vigorous shaking (called ‘succusion’)
between dilutions. This process is called ‘potentization’ and the more times
the dilution and shaking is done, the more potent the remedy. The final
remedy can be so dilute that no molecule of the original substance may be
present. Theories of a mechanism of action include electromagnetic
interactions, ‘memory of water’ and chaos theory. (Micozzi 2001)
Homoeopathic treatment is
selected based on the total picture of the person and their symptoms, not
just the symptoms of the illness. Various aspects of the person are
considered including their lifestyle, emotions, mental state and nutrition.
Back to top
4.
Objectives
The aim of this review
is to assess the potential benefits and harms of homoeopathy for the
treatment of side-effects of cancer treatment and symptoms of cancer.
Back to top
5.
Criteria
for including studies
Types of study:
Published systematic reviews, randomised or non-randomised controlled
trials of homoeopathy versus no treatment, placebo/sham treatment or other
therapeutic interventions, limited to the English language.
Types of participants:
People with cancer or a history of cancer.
Types of intervention:
Homoeopathic treatment versus no treatment, placebo/sham treatment or other
treatments.
Types of outcome measure:
Amount and/or intensity
of symptoms in cancer patients and cancer survivors including quality of
life and general well-being.
Exclusions:
No exclusions
Back to top
6.
Search
strategy
We searched the
following databases in May 2006: AMED, The Cochrane Library, MEDLINE, and
CINAHL. We also checked the reference lists of publications retrieved by the
search for further relevant studies. We also searched the World Wide Web for
any other relevant studies.
7.
Data
collection, analysis and development of recommendations
We used the
above search strategy to obtain titles and abstracts of studies that were
potentially relevant to this review. Where studies met the criteria for
inclusion, they were assessed in full text. The quality of each study was
evaluated using the GATE criteria (http://www.health.auckland.ac.nz/population-health/epidemiology-biostats/epiq/)
for the evaluation of RCTs and systematic reviews.
Only one systematic review
was found and its quality was assessed to be fair. The studies were highly
heterogeneous in all aspects and no meta-analysis was done. Therefore each
study included in this systematic review was looked at separately.
The overall quality of the
body of evidence (including all the included studies) was graded according
to the NZGG CAM levels of evidence system
(reference).
Relevant data were
extracted from the studies selected for inclusion.
Back to top
8.
Description of studies
Summary details of the
systematic review:
|
Study
details |
Participants/studies |
Intervention and comparison(s) |
Outcomes measured |
Comment |
|
Millazzo
2006 |
Included studies: 5 RCTs and 1 CCT
N
(range)=27–83
Patients with cancer or past experience with cancer |
Single
or combined homoeopathic treatment as sole treatment or adjuvant
treatment
vs no treatment, placebo or other
treatments |
Improvement of symptoms
Tumour response
Quality of life |
The
methodological quality of
two of the included studies was poor.
No
meta-analysis because of high heterogeneity
Poor
reporting |
Summary
details of the studies included in the systematic review:
|
Study
details |
Participants/studies |
Intervention and comparison(s) |
Outcomes measured |
Comment |
|
Kulkarni
1988 |
82
patients with cancer undergoing radiation therapy |
Two
single homoeopathic remedies (Cobaltum or
Causticum)
vs placebo
Follow-up not specified |
Degree
of radiation reaction |
RCT
with three parallel arms
Results of statistical analysis not reported
Randomization method not described
No
adverse events reported
Incomplete information regarding patients |
|
Oberbaum
1998 |
27
children and teenagers with leukaemia and chemotherapy-induced
stomatitis
Mean
age 12.3yrs (treated group) and 11.29 yrs (untreated group)
Age
range 6-18 years |
Homoeopathic treatment (Traumeel S®)
vs no
treatment
Follow-up not specified |
Opiates for pain
Duration of symptoms
Quality of life |
Non-randomised
CCT
No
statistical analysis given for differences in duration between the
groups
No
adverse events reported
|
|
Balzarini
2000 |
66
women with breast cancer and undergoing radiotherapy
Mean
age 52.7 years (range 28.3–70.0yrs) |
Homoeopathic remedies Belladonna 7cH and X-ray 15cH
vs
placebo
Follow-up 10 weeks |
Skin
heat
Hyper-pigmentation
Erythema
Oedema
Total
severity of symptoms |
Double-blind RCT
Randomisation
method not described
Allocation concealment not described
Good
methodological quality (4/5 on the Jadad score)
Adverse events reported
|
|
Oberbaum
2001 |
32
patients with various cancers and undergone bone marrow
transplantation
Mean
age 10.1 yrs (treatment group) and 9.7 yrs (placebo group)
Age
range 3–25 years
17
male; 15 female
|
Homoeopathic treatment (Traumeel S®)
vs no
treatment
Follow-up 44 weeks |
Occurrence of stomatitis
Time
to worsening of symptoms
Oral
pain |
Double-blind RCT
Randomisation method not described
Allocation concealment described
Drop-outs: one in each group (6%) -not included in analysis
ITT
analysis
Good
methodological quality (4/5 on the Jadad score)
Adverse events reported in both groups
|
|
Jacobs
2005 |
83
women with breast cancer who had completed all surgical,
chemotherapy and radiotherapy treatments with a history of hot
flushes for 1 month with an average ≥3 hot flushes per day for at
least one week
Mean
age 55.4, 56.8 and 54.5 years (combination remedy, single remedy and
placebo respectively)
|
Combination homoeopathic remedy (‘Hyland’s menopause’)
Single
homoeopathic remedy (selected from 35 different remedies)
vs
placebo
Follow-up 1 year |
Severity and frequency of hot flushes
Quality of life |
Triple-blind RCT
Randomisation method described
Allocation concealment described
Drop-out/withdrawal rate 39% (32/83)
ITT
analysis
Good
methodological quality (5/5 on the Jadad score)
Adverse events reported in combination group
Small
sample size |
|
Thompson
2005 |
53
women with breast cancer experiencing >3 hot flushes per day, not on
treatment for the hot flushes, with no severe concurrent illnesses
and not (or going to be) undergoing chemotherapy
Mean
age 53.6 and 51.6 years (treatment vs placebo) |
Individualised homoeopathic treatment
vs
placebo
Follow-up 16 weeks |
MYMOP
scores (measures symptoms, activities of daily living and general
well-being)
Frequency and severity of hot flushes
Quality of life |
Double-blind RCT
Randomisation method described
Allocation concealment described
Drop-out/withdrawal rate 15% (8/53)
ITT
analysis
Good
methodological quality
(5/5 on the Jadad score)
Adverse events not specified
|
9.
Methodological quality
The systematic review
was assessed to be of fair quality. The studies where highly heterogeneous
in almost every aspect therefore no meta-analysis was performed.
Consequently we looked at each individual study. The methodological quality
of the first two (Kulkarni, Nagarkar et al. 1988; Oberbaum 1998) was poor
and the other four (Balzarini, Felisi et al. 2000; Oberbaum, Yaniv et al.
2001; Jacobs, Herman et al. 2005; Thompson, Montgomery et al. 2005) was
good.
Back to top
10.
Results
Radiotherapy
side-effects
Kulkarni (Kulkarni,
Nagarkar et al. 1988) conducted a study to assess the effectiveness of
homoeopathy on radiotherapy side effects. The reaction to radiation was
evaluated once a week using an 18-point scale. The reaction index was lower
in both intervention groups compared to placebo (5 or ‘minimal reaction’ vs
8.5 or ‘moderate but tolerable reaction’ respectively). The statistical
analysis was not reported. Information regarding patients, remedies and
randomisation was incomplete.
Chemotherapy-induced stomatitis
The effect of a
homoeopathic remedy (Traumeel
S®) on chemotherapy-induced stomatitis (mouth sores) was tested in a
case-control study (Oberbaum 1998) of 20 children and teenagers. In all
patients, the homoeopathic treatment immediately reduced pain. Symptom
duration was reduced in the treatment group (6 vs 13 days in the control
group). No statistical analysis was given.
The authors of this study
carried out a larger RCT (Oberbaum, Yaniv et al. 2001) to test the
effectiveness of Traumeel S® for chemotherapy-induced stomatitis in children
undergoing bone marrow transplant. There was a significant reduction in
severity and/or duration of stomatitis in the treatment group compared to
the placebo group (p<0.01). Also a significant difference was found in the
time it took for symptoms to worsen; it took longer for the symptoms to
worsen in the treatment group. Five patients in the treatment group did not
develop stomatitis compared to one from the placebo group. Seven patients in
the treatment group had worsening of symptoms compared to 14 in the placebo
group.
Skin
reactions as a result of radiotherapy
Balzarini (Balzarini,
Felisi et al. 2000) investigated the effect of homoeopathy on skin reactions
as a result of radiotherapy treatment for breast cancer. Significantly less
hyperpigmentation at week 5 and significantly less heat at week 8 were
observed. However, these were not significant at the end of week 10
follow-up. Total severity score was significantly less during the recovery
period. A significantly high frequency of oedema
was seen in the treatment group at week 5 and 6 but this became
non-significant at weeks 7 and 8.
Menopausal symptoms in breast cancer survivors
Jacobs (Jacobs, Herman et
al. 2005) investigated the effect of homoeopathy on menopausal symptoms in
breast cancer survivors. A wide range of homoeopathic remedies (35) were
used for the single remedies. No significant difference was found for
severity and frequency of hot flushes. A significant improvement in general
health score was found in each homoeopathic group. In a subgroup analysis of
those women not taking tamoxifen, there was a significant increase in both
severity and total number of hot flushes in the combination homoeopathy
group compared to the placebo and single remedy groups. A significant
increase in headaches was noted in the combination group as well.
Another study (Thompson,
Montgomery et al. 2005) investigated the effect of homoeopathy on
oestrogen
withdrawal symptoms in women who have survived breast cancer. They found no
significant differences between the treatment and placebo group in any
outcome measure. About one quarter of participants experienced adverse
events in both groups but no significant difference was found between each
group.
|
Author |
Main results |
|
Kulkarni |
Radiation reaction lower in both treatment groups |
|
Oberbaum |
Decrease in duration of symptoms in treatment group |
|
Oberbaum |
Reduction in the severity and/or duration of stomatitis |
|
Balzarini |
Total
severity during recovery was less |
|
Jacobs
|
No
significant difference was found for severity and frequency of hot
flushes.
Improvement in general health score after 1 year
In the
combination homoeopathy group of women not taking tamoxifen:
increase in severity of hot flushes
increase in total number of hot flushes
increase in headaches |
|
Thompson |
No
significant difference was found in any outcome measure |
Back to top
11.
Discussion of findings
There were only
6 studies included in this review of varying quality. The evidence is
limited and there is the possibility of publication bias.
In the treatment of
side-effects of radiotherapy, one study found that the reaction to
radiotherapy was less in the homoeopathy treatment group. However this study
was judged to be of poor quality so its conclusions must be interpreted with
caution.
For the treatment of
chemotherapy-induced stomatitis, the results from two studies suggest some
benefit of homoeopathy in reducing the severity and duration of mouth
ulcers.
Another study found that
homoeopathic treatment for skin reactions to radiotherapy reduced the total
severity of skin reactions during recovery. There was also a suggestion of
some lessening of heat and hyperpigmentation at times during the
radiotherapy treatment.
Two studies of homoeopathic
treatment of menopausal symptoms in breast cancer survivors found no effect
on severity or frequency of hot flushes. One of these studies found an
improvement in general health after one year. In a subgroup of this study,
there was an increase in number and severity of hot flushes taking the
combination remedy and an increase in the number of headaches.
Back to top
12.
Conclusion
There is
level 4
evidence that homoeopathy may reduce side-effects of radiotherapy.
There is
level 3 evidence
that a particular homoeopathic treatment (Traumeel S®) may reduce the
severity and duration of chemotherapy-induced stomatitis.
There is
level 3 evidence
that homoeopathy may reduce the total severity of skin reaction to
radiotherapy.
There is
level 2 evidence
that homoeopathy does not reduce severity or frequency of menopausal
symptoms in breast cancer survivors.
Back to top
13.
References
Balzarini, A.,
E. Felisi, et al. (2000). "Efficacy of homeopathic treatment of skin
reactions during radiotherapy for breast cancer: a
randomised, double-blind clinical trial." British Homoeopathic
Journal 89(1): 8-12.
Jacobs, J., P. Herman, et al. (2005).
"Homeopathy for menopausal symptoms in breast cancer survivors: a
preliminary randomized controlled trial.[see comment]." Journal of
Alternative & Complementary Medicine 11(1): 21-7.
Kulkarni, A., B. M. Nagarkar, et al. (1988).
"Radiation protection by use of homoeopathic medicines."
Hahnemann Homoeopath Sand 12(1): 20-3.
Micozzi, M. S. (2001).
Fundamentals of Complementary and Alternative Medicine.
Philadelphia, Churchill Livingston.
Milazzo, S., N. Russell, et al. (2006).
"Efficacy of homeopathic therapy in cancer treatment. [Review] [26 refs]."
European Journal of Cancer 42(3): 282-9.
Molassiotis, A., P. Fernadez-Ortega, et al.
(2005). "Use of complementary and alternative medicine in cancer patients: a
European survey." Annals of Oncology 16(4): 655-63.
Oberbaum, M. (1998). "Experimental treatment
of chemotherapy-induced stomatitis using a homeopathic complex preparation:
a preliminary study." Biomed Ther 16(4): 261-5.
Oberbaum, M., I. Yaniv, et al. (2001). "A
randomized, controlled clinical trial of the homeopathic medication TRAUMEEL
S in the treatment of chemotherapy-induced stomatitis in children undergoing
stem cell transplantation." Cancer 92(3): 684-90.
Thompson, E. A., A. Montgomery, et al. (2005).
"A pilot, randomized, double-blinded, placebo-controlled trial of
individualized homeopathy for symptoms of estrogen withdrawal in
breast-cancer survivors.[see comment]." Journal of Alternative &
Complementary Medicine 11(1): 13-20.
Vickers, A. and C. Zollman (1999). "ABC of
complementary medicine. Homoeopathy.[see comment]. [Review] [0 refs]."
Bmj 319(7217): 1115-8.
Back to top
Date prepared:
20 June 2006
DISCLAIMER: This website does not provide specific medical advice and the information provided should not be used as a substitute for seeking medical advice from a registered health practitioner. Full disclaimer . . .